NTNoa Tal

Noa Tal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Noa Tal has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Raanan Shamir

    Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children’s Medical Center of Israel , Petah Tikva 49202

    2 shared publications
  • Angela Maria Savino

    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Edmond and Lily Safra Children's hospital Chaim Sheba Medical Center, Tel Hashomer, Israel

    1 shared publication
  • Arndt Borkhardt

    Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty Heinrich Heine University Düsseldorf Düsseldorf Germany

    1 shared publication
  • Arne Gehlhaar

    Medizinische Fakulaet Heidelberg, Heidelberg University , Heidelberg 69117

    1 shared publication
  • Arnon Nagler

    Division of Hematology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

    1 shared publication
  • Atar Lev

    Immunology Service, Edmond and Lily Safra Children's Hospital, Sheba Medical Center , Ramat-Gan 52621

    1 shared publication

Latest Publications

  • RELA Haploinsufficiency Manifesting as an Atypical Phenotype of Crohn’s Disease

    by Noa Tal, Liran Baram, Arne Gehlhaar, Weihong Gu, Siqi Guo, Eduardo Gonzalez Santiago, Atar Lev, Ortal Barel, Raanan Shamir, Raz Somech, et al.

    Background: Mutations in RELA, a key component of NF-κB signaling, are associated with dysregulated immune responses and inflammatory disorders. While immunodeficiency phenotypes associated with RELA haploinsufficiency have been reported, gastrointestinal manifestations remain poorly described. This study aimed to characterize the clinical, genomic, and immunological features of a patient presenting with an atypical Crohn’s-like phenotype driven by RELA haploinsufficiency. Methods: Whole-exome sequencing was performed, and results were confirmed by Sanger sequencing. Protein modeling, Western blotting, immunofluorescence, and nuclear extract-based NF-κB activation assays were conducted to assess the functional impact of the identified variant. Immune profiling was performed using mass cytometry time of flight (CyTOF) and single-cell RNA sequencing (scRNA-seq) and compared to controls. Results: We studied a 17-year-old male diagnosed with pan-enteric Crohn’s disease (CD), perianal fistulas, chronic mucocutaneous candidiasis, and chronic lymphopenia. Sequencing identified a heterozygous missense variant in RELA (c.587T>C, p.V196A) that potentially impairs RelA (p65) protein stability, confirmed by reduced activity and diminished protein expression. CyTOF analysis revealed decreased circulating T regulatory cells (Tregs), absence of mucosal Tregs, high apoptotic rates, and elevated IFN-γ induced levels, while scRNA-seq demonstrated a robust type I/II interferon signature in multiple immune subsets. Dysregulated mucosal-associated invariant T (MAIT) and cytotoxic CD4+ T cells exhibited upregulation of IL23R and ADAM12, further linking RELA dysfunction to enhanced pro-inflammatory T cell response and tissue inflammation. Conclusion: This study links RELA haploinsufficiency with CD-like features, Th1/Th17 polarization, and interferon-driven inflammation, emphasizing the importance of genetic evaluation in patients with atypical or refractory IBD.


  • Maintenance‐phase serum anti‐TNF levels are not associated with mucosal healing in pediatric Crohn's disease

    by Rinat Grabovski, Stav Regev, Manar Matar, Yael Weintraub, Raanan Shamir, Dror S. Shouval, Noa Tal

    Objectives: Mucosal healing (MH) is a key therapeutic target in Crohn's disease (CD) and is associated with improved outcomes. While adult studies indicate a positive correlation between serum anti‐tumor necrosis factor (TNF) levels and MH, data in pediatric patients is limited. We aimed to define the association of serum anti‐TNF levels with MH in pediatric patients with CD during maintenance therapy.Methods: Retrospective data (2014–2023) was collected from pediatric CD patients treated with infliximab or adalimumab who performed an ileocolonoscopy at least 26 weeks after initiating therapy. Serum anti‐TNF levels around endoscopic time were compared with endoscopic findings. MH was defined as complete absence of inflammatory or ulcerative lesions across all segments of the gastrointestinal tract. Univariable and multivariable logistic regression analysis was conducted to identify factors associated with MH.Results: Data were obtained from 107 patients (41 infliximab and 66 adalimumab), with a median age at diagnosis of 12.6 (9.9–14.0) years. Median time until ileocolonoscopy following anti‐TNF initiation was 89.0 (56.3–152.3) weeks. MH was identified in 31 (29.0%) patients. Anti‐TNF serum levels were comparable in the MH and non‐MH groups (9.5 [4.9–13.9] vs. 9.3 [6.4–15.7] µg/mL; p = 0.73), without differences in patients treated with infliximab or adalimumab. In multivariable analysis, diagnosis weight Z‐score (odds ratio [OR] = 2.860, 95% confidence interval [CI] = 1.005–8.138; p = 0.049), along with C‐reactive protein (OR = 0.037, 95% CI = 0.002–0.687; p = 0.027) and fecal calprotectin (OR = 0.995, 95% CI = 0.990–1.000; p = 0.037) at time of ileocolonoscopy were significantly associated with MH.Conclusions: In our cohort, anti‐TNF levels during maintenance were not associated with MH in pediatric CD.


  • Orbital Cellulitis in a Pediatric Population - Experience From a Tertiary Center

    by Noa Tal Shifman, Irit Krause, Gad Dotan, Dror Gilony, Efraim Bilavsky

    Objective To describe our experience in treating children afflicted with orbital cellulitis. Methods A retrospective analysis of hospital records of children afflicted with orbital cellulitis was conducted between 2005–2018. Clinical, laboratory and radiology characteristics as well as management, microbiological data, and outcomes were collected. Results Of the 94 patients, painful restriction of ocular motility was observed in 37.2% and proptosis in 34%, whereas, only 18% of the children presented with both classical signs. Children aged older than 9 years presented with markedly elevated inflammatory markers i.e., leukocytosis and C-reactive protein (CRP). Only a minority (12, 12.4%) required functional endoscopic sinus surgery. Conclusion Our data support the general approach that orbital cellulitis should be initially managed conservatively with close monitoring; since, only a minority of patients require surgical intervention.


  • Open Access

    An instructive role for IL7RA in the development of human B-cell precursor leukemia

    by Ifat Geron, Angela Maria Savino, Noa Tal, John Brown, Virginia Turati, Chela James, Jolanda Sarno, Yu Nee Lee, Avigail Rein Gil, Hila Fishman, et al.

    B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is preceded by a clinically silent pre-leukemia. Experimental models that authentically re-capitulate disease initiation and progression in human cells are lacking. We previously described activating mutations in interleukin 7 receptor alpha (IL7RA) that are associated with the poor-prognosis Philadelphia-like (Ph-like) subtype of BCP-ALL. Whether IL7RA signaling has a role in initiation of human BCP-ALL is unknown.IL7RA is essential for mouse B-cell development; however, patients with truncatingIL7RAgermline mutations develop normal mature B-cell populations. Herein, we explore the consequences of aberrant IL7RA signaling activation in human hematopoietic progenitors on malignant B-cell development.Transplantation of human cord-blood hematopoietic progenitors transduced with activated mutant IL7RA into NOD/LtSz-scid IL2Rγnullmice resulted in B-cell differentiation arrest with aberrant expression of CD34+and persistence of pro-B cells that survive despite failing to achieve productive rearrangement of immunoglobulin V(D)J gene segments. Activation of IL7RA signaling enhanced self-renewal and facilitated the development of a BCP-ALL in secondary transplanted mice. The development of leukemia was associated with spontaneous acquired deletions in CDKN2A/B and IKZF1 similar to what is observed in Ph-like BCP-ALL in humans. Single cell gene expression analysis suggested that pre-leukemic cells resided within a subpopulation of early B-cell precursors with CD34+CD10highCD19lowimmunophenotype.The development of a bona fide BCP-ALL from IL7RA transduced cells supports the hypothesis that aberrant activation of the IL7RA pathway in human B-cell lineage progenitors has an instructive role by creating a pre-leukemic state which is vulnerable to transformation. These are the first demonstrations of a role for IL7RA in human B-cell differentiation and of a de-novo Ph-like BCP-ALL development from normal human hematopoietic progenitorsin vivo.